Form 4: UNH Executive Noel Reports Stock and Option Grants

UnitedHealth Group's UHC CEO Timothy Noel reported the acquisition of restricted stock units and non-qualified stock options, alongside a minor stock disposal for tax purposes.

Summary

• Timothy John Noel, Chief Executive Officer of UHC, reported transactions involving UnitedHealth Group Inc. (UNH) common stock and derivative securities.
• On February 23, 2026, Noel disposed of 123.171 shares of common stock at a price of $282.34 per share, likely for tax withholding purposes related to vesting.
• Concurrently, Noel acquired 8,855 shares of common stock, which are restricted stock units (RSUs) with a transaction price of $0.
• These restricted stock units are scheduled to vest at a rate of 25% annually on February 23 from 2027 through 2030.
• Noel also acquired 35,517 non-qualified stock options with an exercise price of $282.34 and a transaction price of $0.
• These non-qualified stock options are also scheduled to vest at a rate of 25% annually on February 23 from 2027 through 2030, and have an expiration date of February 23, 2036.
• Following these transactions, Noel beneficially owns 17,472.324 shares of common stock directly and 35,517 non-qualified stock options directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting routine executive compensation that aligns management's interests with long-term shareholder value, without indicating any significant operational or financial changes.

Positives

• Timothy John Noel received a grant of 8,855 restricted stock units, aligning his interests with long-term company performance.
• Noel was granted 35,517 non-qualified stock options, providing an incentive for future stock price appreciation.

Negatives

• A disposal of 123.171 shares of common stock occurred, though this is a common practice for tax withholding upon the vesting of equity awards and not indicative of a sell-off.

Future Outlook

The filing indicates a future vesting schedule for restricted stock units and non-qualified stock options, with 25% vesting annually from February 23, 2027, through February 23, 2030. The non-qualified stock options have an expiration date of February 23, 2036.

Industry Context

StockSavvy.ai notes that the grant of restricted stock units and non-qualified stock options to a key executive like Timothy Noel is a standard practice in the healthcare and insurance industry. This compensation structure is designed to align executive incentives with shareholder value creation over the long term, a common strategy among large, established companies like UnitedHealth Group.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) and non-qualified stock options as part of executive compensation is a prevalent practice across the S&P 500, including major healthcare peers such as Elevance Health (ELV) and Cigna Group (CI).
• The vesting schedule of 25% annually over four years is typical for long-term incentive plans, comparable to those observed at companies like CVS Health (CVS) for their executive equity awards.
• The disposal of shares for tax withholding (Code 'F') is a standard mechanism for executives to cover tax obligations upon the vesting of equity awards, consistent with practices at other large public companies.

Stakeholder Impact

• Shareholders: The equity grants align the executive's financial interests with the company's long-term performance, potentially benefiting shareholders through sustained growth.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The restricted stock units and non-qualified stock options will vest at a rate of 25% annually on February 23 from 2027 through 2030.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation in the form of restricted stock units and stock options, along with a tax-related share disposal. Such transactions are standard and do not typically alter the fundamental investment thesis for UnitedHealth Group. A seasoned investor would likely maintain their current position, as this filing provides no new information to warrant a change in recommendation.

Keywords

UnitedHealth Group, UNH, Timothy Noel, Form 4, Insider Transaction, Restricted Stock Units, Stock Options, Executive Compensation, Equity Grant